Amid the COVID-19 crisis, the global market for Laboratory Automation Systems estimated at US$4.6 Billion in the year 2020, is projected to reach a revised size of US$6.4 Billion by 2027, growing at a CAGR of 4.8% over the period 2020-2027.
Clinical, one of the segments analyzed in the report, is projected to record 4.9% CAGR and reach US$4.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Drug Discovery segment is readjusted to a revised 4.4% CAGR for the next 7-year period.
The U. S. Market is Estimated at $1.4 Billion, While China is Forecast to Grow at 4.5% CAGR
The Laboratory Automation Systems market in the U. S. is estimated at US$1.4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2027 trailing a CAGR of 4.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.4% and 4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.
The report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Competitors identified in this market include, among others:
Abbott Diagnostics
Agilent Technologies, Inc.
Aurora Biomed, Inc.
Becton, Dickinson and Company
Becton, Dickinson and Company
bioMerieux SA
BioTek Instruments, Inc.
Brooks Automation, Inc.
Cerner Corporation
Danaher Corporation
Eppendorf AG
F. Hoffmann-La Roche AG
LabVantage Solutions, Inc.
LabWare, Inc.
Olympus Corporation
PerkinElmer, Inc.
QIAGEN NV
Sartorius Stedim Biotech SA
Siemens Healthineers
SOTAX AG
Tecan Group Ltd.
Thermo Fisher Scientific, Inc.
Key Topics Covered:
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
Laboratory Automation Systems Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Laboratory Automation Systems Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
Laboratory Automation Systems Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019
Laboratory Automation Systems Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
Clinical (End-Use) Global Opportunity Assessment in US$ Million by Region/Country: 2020-2027
Clinical (End-Use) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019
Clinical (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027
Drug Discovery (End-Use) Worldwide Sales in US$ Million by Region/Country: 2020-2027
Drug Discovery (End-Use) Historic Demand Patterns in US$ Million by Region/Country: 2012-2019
Drug Discovery (End-Use) Market Share Shift across Key Geographies: 2012 VS 2020 VS 2027
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
Market Facts & Figures
Laboratory Automation Systems Market Share (in %) by Company: 2019 & 2025
Market Analytics
Laboratory Automation Systems Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027
Laboratory Automation Systems Historic Demand Patterns by End-Use in US$ Million for 2012-2019
Laboratory Automation Systems Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein") announces that a federal securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of investors who purchased...
Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals, is happy to announce that its wholly owned generic pharmaceutical subsidiary, Nora...
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against QuidelOrtho Corporation ("QuidelOrtho" or "the Company") for violations of 10(b) and 20(a) of the Securities...
YS Biopharma Co., Ltd. ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and...